Search
Displaying results 451 to 460 of 596.
New epidemic management system combats monkeypox outbreak in Nigeria
Johanna Wanka, German Federal Minister of Research, said: "The dramatic experience of the Ebola epidemic in West Africa has made it very clear that the national and international emergency planning for epidemics of this type was insufficient. SORMAS shows, in an…
Detection of bacterial biofilms using covalent lectin binders
Bacteria of the Pseudomonas aeruginosa species are hospital germs and are resistant to many common antibiotics. They can infect all organs and implants and form so-called biofilms, in which they are protected and survive for long periods of time. This results in a…
Große Bühne für Wissenschaft in drei Minuten
Bühne frei für die Wissenschaft heißt es am Donnerstag, 9. April 2015 ab 19 Uhr auf dem Campus des Helmholtz-Zentrums für Infektionsforschung (HZI) in Braunschweig. Beim regionalen Vorentscheid Niedersachsen des FameLab-Wettbewerbs präsentieren Nachwuchswissenschaftler…
Antibiotic nanoparticles attack respiratory infection
Treating respiratory disease is often difficult because drugs have to cross biological barriers such as respiratory tissue and mucosa, and must therefore be given in large quantities in order for an effective amount to reach the target. Now researchers from Germany,…
An Atlas of Pseudomonas genes
Certain proteins play a crucial role in the processing of genetic information by bacteria: The so-called sigma factors are responsible for the start of transcription, i.e. the process of making RNA from DNA. Recently, Scientists of the Helmholtz Centre for Infection…
Protein renders Yersiniae harmless
Bacteria of the Yersinia genus cause thousands of cases of diarrhoeal disease each year, often with serious consequences. To survive and proliferate in the host, the pathogens first have to adapt, though. Scientists at the Helmholtz Centre for Infection Research (HZI)…
New professorship at the Centre for Structural Systems Biology
How do bacterial pathogens gain entry into our cells and how do they make us ill? Those are the questions that will be investigated by the biochemist Michael Kolbe at the Centre for Structural Systems Biology (CSSB) in Hamburg starting from February 2015. He and his…
An enzyme tunnel in 3D
At high resolution and in 3D - Scientists from the Helmholtz Centre for Infection Research (HZI) and the University of Basel solved the structure of the enzyme, EgtB. Some bacteria utilise EgtB to produce the vitamin ergothioneine, for example Mycobacterium tuberculosis…
Influenza vaccine less effective than expected
The effectiveness of this season's influenza vaccine appears to be less than optimal. The vaccine must be expected to be less effective against one of the three circulating types of the virus, as reported by the Robert Koch-Institute (RKI). Prof Klaus Schughart, head of…
Ineffective Helper Cells
The IKBNS protein is very important for the development of immune cells: Two years ago, it was discovered that regulatory T cells, so-called Tregs, do not develop in the absence of this protein. The IKBNS protein also plays a role in the development of another type of…
